MDC Berlin

Digitalization is having a rapid impact in the field of medicine, with data sciences and AI offering ever-increasing benefits for the development of new vaccines and drugs. Pfizer manager Peter Albiez discusses how graduate schools like HEIBRiDS are helping meet the enormous demand for specialists in the data sciences.

There’s likely to be a fundamental difference between how a medical practicioner and an artist view genetic editing with CRISPR. But both perspectives reveal possible ways to shape life in nature. Science meets art: the Max Delbrück Center at the Salon Sophie Charlotte 2022 in Berlin.

Translucent and offering abundant space for communication to systems biologists at the BIMSB: The Association of German Architects has praised the building of the Max Delbrück Center for Molecular Medicine (MDC), which was be completed in 2019, at the “BDA Prize Berlin”.

Stem cells in the bone marrow form the cells of the blood throughout life. In the process, mistakes can occur leading to cancer. Together with a research team from Berlin, Heidelberg and Boston, Simon Haas describes in "Cell Stem Cell" a mechanism that allows the body to protect itself from this risk.

On Girls' Day, researchers at the Max Delbrück Center for Molecular Medicine (MDC) shared their thoughts on bioinformatics and let the students work with data sets and programs themselves. The bottom line: research is fun – even though or even because the tasks are complex.

On April 25, 2022, Federal Commissioner for East Germany, Minister of State Carsten Schneider, and Governing Mayor of Berlin Franziska Giffey visited Campus Berlin-Buch to see how the “Zukunftsort” (place of the future) is developing.

Christian Stadelmann has been fascinated by CRISPR/Cas9 gene editing since he was an undergrad. Now, the PhD student is investigating the possibility of applying it to treat hereditary muscular dystrophy in Professor Simone Spuler's research group at the ECRC.

Research teams at the MDC and partner institutions used a total of 52,132 animals in studies conducted in 2021 at the MDC’s locations in Berlin-Buch and Mitte. The MDC has now submitted these figures to the regulatory authority, the Berlin State Office for Health and Social Affairs (LaGeSo).

In order to put their genetic blueprints into action, human cells need RNA-binding proteins. Markus Landthaler observes these proteins while they interact with RNA – in order to understand how they work, and how to make use of them.